T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.49B |
| 2 |
Micron Technology
MU
|
+$6.62B |
| 3 |
Lam Research
LRCX
|
+$3.45B |
| 4 |
Applied Materials
AMAT
|
+$3.03B |
| 5 |
Advanced Micro Devices
AMD
|
+$2.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.1B |
| 2 |
Apple
AAPL
|
+$11.6B |
| 3 |
Amazon
AMZN
|
+$3.54B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.07B |
| 5 |
Keysight
KEYS
|
+$1.82B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.73% |
| 2 | Healthcare | 11.3% |
| 3 | Financials | 10.32% |
| 4 | Communication Services | 9.66% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Canterbury Park Holding Corp
CPHC
$82.2M
| $199K | ﹤0.01% |
12,565
+1,318
| +12% | +$20.8K |
|
3002
Lineage Cell Therapeutics
LCTX
$260M
| $199K | ﹤0.01% |
+151,233
| New | +$209K |
|
3003
National CineMedia
NCMI
$224M
| $199K | ﹤0.01% |
52,321
| – | – |
|
3004
SES AI
SES
$193M
| $199K | ﹤0.01% |
+206,844
| New | +$225K |
|
3005
OmniAb
OABI
$583M
| $198K | ﹤0.01% |
80,106
+3,066
| +4% | +$6.09K |
|
3006
Aemetis
AMTX
$132M
| $197K | ﹤0.01% |
119,806
+86,043
| +255% | +$210K |
|
|
KBDC
3007
Kayne Anderson BDC
KBDC
$863M
| $195K | ﹤0.01% |
14,407
-1,748
| -11% | -$25.2K |
|
|
UPB
3008
Upstream Bio Inc
UPB
$326M
| $195K | ﹤0.01% |
28,058
+1,624
| +6% | +$13.6K |
|
3009
LCNB Corp
LCNB
$270M
| $194K | ﹤0.01% |
+11,027
| New | +$184K |
|
3010
Universal Electronics
UEIC
$60M
| $194K | ﹤0.01% |
40,612
+5,926
| +17% | +$24.7K |
|
|
APC
3011
ARKO Petroleum
APC
$908M
| $194K | ﹤0.01% |
+10,277
| New | +$197K |
|
3012
FVCBankcorp
FVCB
$330M
| $192K | ﹤0.01% |
10,955
| – | – |
|
|
GPMT
3013
Granite Point Mortgage Trust
GPMT
$48.2M
| $192K | ﹤0.01% |
127,441
+23,702
| +23% | +$34.1K |
|
3014
Oportun Financial
OPRT
$358M
| $192K | ﹤0.01% |
33,489
+1,756
| +6% | +$9.4K |
|
3015
Smith Douglas Homes
SDHC
$86.7M
| $192K | ﹤0.01% |
12,300
| – | – |
|
3016
Zumiez
ZUMZ
$296M
| $192K | ﹤0.01% |
+10,773
| New | +$241K |
|
|
MH
3017
McGraw Hill
MH
$2.35B
| $192K | ﹤0.01% |
20,187
| – | – |
|
3018
Sidus Space
SIDU
$209M
| $191K | ﹤0.01% |
+67,631
| New | +$259K |
|
3019
Veritone
VERI
$86.2M
| $190K | ﹤0.01% |
138,263
+78,589
| +132% | +$150K |
|
3020
Priority Technology Holdings
PRTH
$447M
| $188K | ﹤0.01% |
28,178
+8,930
| +46% | +$51.7K |
|
3021
OppFi
OPFI
$642M
| $187K | ﹤0.01% |
18,764
+654
| +4% | +$5.66K |
|
3022
TAL Education Group
TAL
$6.35B
| $187K | ﹤0.01% |
19,487
+4,587
| +31% | +$48.2K |
|
3023
ALX Oncology
ALXO
$254M
| $186K | ﹤0.01% |
+89,779
| New | +$161K |
|
3024
GoPro
GPRO
$293M
| $184K | ﹤0.01% |
236,287
+139,524
| +144% | +$147K |
|
3025
Galectin Therapeutics
GALT
$408M
| $183K | ﹤0.01% |
+39,313
| New | +$102K |
|
Similar funds
T. Rowe Price Associates's Q2 2026 Portfolio in Review
As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
- T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
- T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
- T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
- T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
- T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.